Divi's Laboratories Limited (BOM:532488)

Divi's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	1,280	4,150	3,630	1,700	12,148
Short-Term Investments	-	31,050	31,120	33,350	39,630	15,269
Cash & Short-Term Investments	32,330	32,330	35,270	36,980	41,330	27,417
Cash Growth	-8.34%	-8.34%	-4.62%	-10.53%	50.75%	31.76%
Accounts Receivable	-	31,090	27,310	21,560	17,930	24,239
Other Receivables	-	3,420	2,460	2,050	1,410	1,045
Receivables	-	34,510	29,770	23,610	19,340	25,283
Inventory	-	39,540	32,360	31,840	30,000	28,286
Prepaid Expenses	-	260	370	360	260	270.9
Other Current Assets	-	4,320	3,040	3,960	2,190	2,258
Total Current Assets	-	110,960	100,810	96,750	93,120	83,515
Property, Plant & Equipment	-	86,350	64,600	55,130	49,290	47,875
Long-Term Investments	-	690	650	820	770	720.1
Other Intangible Assets	-	60	40	40	50	74.9
Long-Term Deferred Tax Assets	-	140	110	100	140	144.7
Other Long-Term Assets	-	2,130	3,110	1,860	1,020	1,418
Total Assets	-	200,330	169,320	154,700	144,390	133,747

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	12,110	9,100	8,240	7,620	7,957
Accrued Expenses	-	4,030	3,650	2,440	2,550	3,235
Short-Term Debt	-	-	20	-	-	-
Current Portion of Leases	-	20	-	10	10	8.2
Current Income Taxes Payable	-	120	-	430	20	16.8
Current Unearned Revenue	-	2,690	410	10	10	7.6
Other Current Liabilities	-	1,460	1,340	1,650	800	731.3
Total Current Liabilities	-	20,430	14,520	12,780	11,010	11,956
Long-Term Leases	-	50	20	20	30	28.7
Pension & Post-Retirement Benefits	-	810	-	-	-	-
Long-Term Deferred Tax Liabilities	-	4,690	5,090	5,820	5,370	4,214
Other Long-Term Liabilities	-	6,740	-	370	310	267.1
Total Liabilities	-	32,720	19,630	18,990	16,720	16,465

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	530	530	530	530	530.9
Additional Paid-In Capital	-	800	800	800	800	798.8
Retained Earnings	-	165,820	148,050	134,120	126,090	115,797
Comprehensive Income & Other	-	460	310	260	250	155.1
Shareholders' Equity	167,610	167,610	149,690	135,710	127,670	117,282
Total Liabilities & Equity	-	200,330	169,320	154,700	144,390	133,747

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	70	70	40	30	40	36.9
Net Cash (Debt)	32,260	32,260	35,230	36,950	41,290	27,380
Net Cash Growth	-8.43%	-8.43%	-4.66%	-10.51%	50.80%	31.89%
Net Cash Per Share	121.56	121.52	132.71	139.19	155.54	103.14
Filing Date Shares Outstanding	265.68	265.47	265.47	265.47	265.47	265.47
Total Common Shares Outstanding	265.68	265.47	265.47	265.47	265.47	265.47
Working Capital	-	90,530	86,290	83,970	82,110	71,560
Book Value Per Share	631.37	631.37	563.87	511.21	480.92	441.79
Tangible Book Value	167,550	167,550	149,650	135,670	127,620	117,207
Tangible Book Value Per Share	631.15	631.15	563.72	511.06	480.73	441.51
Land	-	3,060	2,020	1,950	1,940	1,727
Machinery	-	66,310	55,000	48,630	45,770	39,860
Construction In Progress	-	21,130	10,220	7,780	2,120	4,699

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error